Mastodynia: pathogenesis, diagnosis, and treatment


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Mastodynia is observed in 70% of women in the population and it occurs more frequently at the age of 30 to 50 years. We reviewed the papers published in the PubMed and RSCI database in the period from 2000 to 2022 in order to systematize the variants of the clinical course, the mechanisms of mastodynia development and individual approaches to the management tactics of patients with breast pain. Mastodynia may be associated with premenstrual syndrome, benign breast dysplasia, mastitis. The risk of breast cancer is extremely low in a situation where the only symptom is mastodynia. The examination of patients with mastodynia includes history taking, physical examination, imaging techniques aimed at identifying functional and organic disorders of the mammary gland. After appropriate clinical evaluation, most patients with breast pain respond positively to non-medication and medication treatment. The results of the clinical studies show the effectiveness of medications containing a dry extract of the fruits of Vitex agnus castus in the treatment of mastodynia in patients with diffuse benign breast dysplasia and premenstrual syndrome. Conclusion: It is necessary to conduct a thorough examination of women with mastodynia in order to exclude proliferative formations of the mammary glands and to identify the cause of breast tenderness. Mechanism-based mastodynia therapy helps to reduce episodes of pain and improve the quality of life while minimizing side effects.

Толық мәтін

Рұқсат жабық

Авторлар туралы

Natalya Kulagina

I.I. Mechnikov Northwestern State Medical University, Ministry of Health of Russia

Email: dr.kulagina@mail.ru
Dr. Med. Sci., Professor, Department of Obstetrics and Gynecology

Vladislav Odintsov

Northern State Medical University, Ministry of Health of Russia; Odintsov Clinic LLC

Email: gec00@yandex.ru
Dr. Med. Sci., Professor, Department of Radiation Diagnostics, Radiation Therapy and Oncology

Әдебиет тізімі

  1. Kataria K., Dhar A., Srivastava A., Kumar S., Goyal A. A Systematic Review of Current Understanding and Management of Mastalgia. Indian J. Surg. 2014; 76(3): 217-22. https://dx.doi.org/10.1007/s12262-013-0813-8.
  2. Goyal A. Breast pain. BMJ Clin. Evid. 2011; 2011: 0812.
  3. Scurr J., Hedger W., Morris P., Brown N. The prevalence, severity, and impact of breast pain in the general population. Breast J. 2014; 20(5): 508-13. https://dx.doi.org/10.1111/tbj.12305.
  4. Hafiz S.P., Barnes N.L.P., Kirwan C.C. Clinical management of idiopathic mastalgia: a systematic review. J. Prim. Health Care. 2018; 10(4): 312-23. https://dx.doi.org/10.1071/HC18026.
  5. Grullon S., Bechmann S. Mastodynia. 2020 Jun 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan.
  6. Протасова А.Э., Вандеева Е.Н. Диффузные заболевания молочной железы: новый вектор таргетной терапии. Гинекология. 2017; 2(19): 42-9.
  7. Eriksson M., Lindh., Uvnas-Moberg K., Hokfelt T. Distribution and origin of peptide-containing nerve fibres in the rat and human mammary gland. Neuroscience. 1996; 70(1): 227-45. https://dx.doi.org/10.1016/0306-4522(95)00291-p.
  8. Peters M.T., Diemer P., Mecks O., Behnken L.L.J. Severity of mastalgia in relation to milk duct dilatation. Obstet. Gynecol. 2003; 101(1): 54-60. https://dx.doi.org/10.1016/s0029-7844(02)02386-4.
  9. Алексеев Н.П. Физиология лактации женщины. М.: Издательство Юрайт; 2019. 300 с.
  10. Smith R.L., Pruthi S., Fitzpatrick L.A. Evaluation and management of breast pain. Mayo Clin. Proc. 2004; 79(3): 353-72. https://dx.doi.org/10.4065/79.3.353.
  11. Fentiman I.S., Hamed H. Assessment of breast problems. Int. J. Clin. Pract. 2001; 55(7): 458-60.
  12. Contreras G.A., Rodriguez J.M. Mastitis: comparative etiology and epidemiology. J. Mammary Gland Biol. Neoplasia. 2011; 16(4): 339-56. https://dx.doi.org/10.1007/s10911-011-9234-0.
  13. Fernandez L., Langa S., Martin V., Maldonado A., Jimenez E. et al. The human milk microbiota: origin and potential roles in health and disease. Pharmacol. Res. 2013; 69(1): 1-10. https://dx.doi.org/10.1016/j.phrs.2012.09.001.
  14. Hurtado J.A., Maldonado-Lobon J.A., Diaz-Ropero M.P., Flores-Rojas K., Uberos J. et al. Administration to Nursing Women of Lactobacillus fermentum CECT5716 Prevents Lactational Mastitis Development: A Randomized Controlled Trial. Breastfeed Med. 2017; 12(4): 202-9. https://doi.org/10.1089/bfm.2016.0173.
  15. Qomqali B., Kocaoz S., Ozdemir B.A., Parlak 0., Korukluoglu B. Effects of sagging breasts and other risk factors associated with mastalgia: a case-control study. Sci. Rep. 2021; 11: 2620. https://doi.org/10.1038/s41598-021-82099-2.
  16. İdiz C., Çakır C., Ulusoy A. İ., İdiz U.O. The role of nutrition in women with benign cyclic mastalgia: A case-control study. Eur. J. Breast Health. 2018; 14(3): 156-9. https://doi.org/10.5152/ejbh.2018.3827
  17. Altintas Y., Bayrak M. Evaluation of 1294 Female Patients with Breast Pain: A Retrospective Study. Adv. Ther. 2018; 35(9): 1411-9. https://doi.org/10.1007/s12325-018-0769-y.
  18. Koqoglu D., Kur§un S., Akin B., Kamile K. Mastalgia and associated factors: a cross-sectional study. Agri. 2017; 29(3): 100-8. https://doi.org/10.5505/agri.2017.91069.
  19. Hadi M.S. Sports brassiere: is it a solution for mastalgia? Breast J. 2000; 6(6): 407-9. https://doi.org/10.1046/j.1524-4741.2000.20018.x.
  20. Радзинский В.Е., Ордиянц И.М., Масленникова М.Н., Павлова Е.А. Молочные железы и гинекологические заболевания: от общности патогенетических воззрений к практическим решениями. Репродуктивная эндокринология. 2014; 2(16): 72-80.
  21. Кузнецова И.В., Бурчакова М.Н., Бурчаков Д.И., Хаджиева Н.Х., Филиппова Г.Г. Психогенные стресс-зависимые нарушения менструального цикла: роль негормональной коррекции. Медицинский алфавит. 2017; 2(10): 54-61.
  22. Yildirim A.C., Yildiz P., Yildiz M., Kahramanca §, Kargici H. Mastalgia-Cancer Relationship: A Prospective Study. J. Breast Health. 2015; 11(2): 88-91. https://doi.org/10.5152/tjbh.2015.2492.
  23. Johnson K.M. Frequency of mastalgia among women veterans: association with psychiatric conditions and unexplained pain syndromes. J. Gen. Intern. Med. 2006; 21(3): 70-5. https://doi.org/10.1111/j.1525-1497.2006.00378.x
  24. Srivastava V., Meena R.K., Ansari M.A., Kumar D., Kumar A. A Study of Anxiety and Depression in Benign Breast Disease. J. Midlife Health. 2020; 11(4): 200-9. https://doi.org/10.4103/jmh.JMH_85_20.
  25. Kanat B.H., Atmaca M., Girgin M., Ilhan Y.S., Bozdag A. et al. Effects of Mastalgia in Young Women on Quality of Life, Depression, and Anxiety Levels. Indian J. Surg. 2016; 78(2): 96-9. https://doi.org/10.1007/s12262-015-1325-5.
  26. Katar M.K., Ba§er M. Relationship Between Mastalgia And Anxiety-Depression: An Observational Study. Cureus. 2021; 13(1): e12734. https://doi.org/10.7759/cureus.12734.
  27. Mirghafourvand M., Ahmadpour P., Rahi P., Salehiniya H. Relationship between depression and anxiety with the severity and length of cyclic mastalgia in women. Iran J. Obstet. Gynecol. Infertil. 2016; 18: 1-7. https://doi.org/10.22038/IJOGI.2016.6559.
  28. Noroozian M. Stein L.F. Gaetke-Udager K. Helvie M.A. Long-term clinical outcomes in women with breast pain in the absence of additional clinical findings: mammography remains indicated. Breast Cancer Res. Treat. 2015; 149: 417-24. https://doi.org/10.1007/s10549-014-3257-3.
  29. Plu-Bureau G., Le M.G., Sitruk-Ware R., Thalabard J.C. Cyclical mastalgia and breast cancer risk: results of a French cohort study. Cancer Epidemiol. Biomarkers Prev. 2006; 15(6): 1229-31. https://doi.org/10.1158/1055-9965.EPI-05-0745.
  30. Salman B., Collins E., Hersh L. Common Breast Problems. Am. Fam. Physician. 2019; 99(8): 505-14.
  31. Jokich P.M., Bailey L., D'Orsi C., Green E.D., Holbrook A.I. et al. ACR Appropriateness Criteria® Breast Pain. J. Am. Coll. Radiol. 2017; 14(5): 25-33. https://doi.org/10.1016/j.jacr.2017.01.028.
  32. Holbrook A.I., Moy L., Akin E.A., Baron P., Didwania A.D. et al. ACR appropriateness criteria: breast pain. J. Am. Coll. Radiol. 2018; 15(11): 276-82. https://doi.org/10.1016/j.jacr.2018.09.014.
  33. Arslan M., Kuqukerdem H.S., Can H., Tarcan E. Retrospective analysis of women with only mastalgia. J. Breast Health. 2016; 12(4): 151-4. https://doi.org/10.5152/tjbh.2016.2944.
  34. Chetlen A.L., Kapoor M.M., Watts M.R. Mastalgia: imaging work-up appropriateness. Acad. Radiol. 2017; 24(3): 345-9. https://doi.org/10.1016/j.acra.2016.10.004.
  35. Groen J.-W., Grosfeld S., Bramer W.M., Ernst M.F., Mullender M.M. Cyclic and non-cyclic breast-pain: A systematic review on pain reduction, side effects, and quality of life for various treatments. Eur. J. Obstet. Gynecol. Reprod. Biol. 2017; 219: 74-93. https://doi.org/10.1016/j.ejogrb.2017.10.018.
  36. Peter C., Alec M., Botsikas D., Wegener S., Perbet E. Mastalgia: management and state of the art. Rev. Med. Suisse. 2022; 18(764-5): 83-7. https://doi.org/10.53738/REVMED.2022.18.764-65.83.
  37. Cornell L.F., Sandhu N.P., Pruthi S., Mussallem D.M. Current Management and Treatment Options for Breast Pain. Mayo Clin. Proc. 2020; 95(3): 574-80. https://doi.org/10.1016Zj.mayocp.2019.12.014.
  38. Ngo C., Seror J., Chabbert-Buffet N. Breast pain: Recommendations. J. Gynecol. Obstet. Biol. Reprod. 2015; 44(10): 938-46. https://doi.org/10.1016/j.jgyn.2015.09.039.
  39. Rosolowich V., Saettler E., Szuck B. Mastalgia. J. Obstet. Gynaecol. Can. 2006; 28(1): 49-57. https://doi.org/10.1016/S1701-2163(16)32027-8.
  40. Mansel R.E., Goyal A., Preece P., Leinster S., Maddox P.R. et al. European randomized, multicenter study of goserelin (Zoladex) in the management of mastalgia. Am. J. Obstet. Gynecol. 2004; 191(6): 1942-9. https://doi.org/10.1016/j.ajog.2004.06.100.
  41. Клинические рекомендации «Доброкачественная дисплазия молочной железы». 2020. 77 с.
  42. Souto E.B., Durazzo A., Nazhand A., Lucarini M., Zaccardelli M. et al. Vitex agnus-castus L.: Main Features and Nutraceutical Perspectives. Forests 2020; 11(7): 761. https://doi.org/10.3390/f11070761.
  43. Seidlova-Wuttke D., Wuttke W. The premenstrual syndrome, premenstrual mastodynia, fibrocystic mastopathy and infertility have often common roots: effects of extracts of chasteberry (Vitex agnus castus) as a solution. Clinical Phytoscience. 2017; 3: 6. https://doi.org/10.1186/s40816-016-0038-z.
  44. ЭльЛкад Е.В., Сотникова Л.С., Тонких О.С., Оккель Ю.В., Федосова Л.Н. и др. Состояние гормональной регуляции при фиброзно-кистозной мастопатии. Мать и дитя в Кузбассе. 2011; 1: 342-6.
  45. Яворская С.Д., Сычева М.С., Кореновский Ю.В. Влияние лекарственного фитопрепарата на уровень гонадотропных гормонов и метаболитов эстрогенов у пациенток с доброкачественными заболеваниями молочных желез в сочетании с масталгией. Акушерство и гинекология. 2019; 1: 126-32 https://doi.org/10.18565/aig.2019.L126-132.
  46. Ашрафян Л.А., Бабаева Н.А., Антонова И.Б., Овчинникова О.А., Алешикова О.И., Моцкобили Т. А., Кузнецов И.Н. Уровень баланса эстрогенных метаболитов при раке молочной железы и пути его коррекции. Опухоли женской репродуктивной системы. 2015; 11(3): 22-9. https://doi.org/10.17650/1994-4098-2015-11-3-22-29.
  47. Сметник А.А., Сметник В.П., Киселев В.И. Опыт применения индол-3-карбинола в лечении заболеваний молочной железы и профилактике рака молочной железы. Акушерство и гинекология. 2017; 2: 106-12. [Smetnik A.A., Smetnik V.P., Kiselev V.I. Experience with indole-3-carbinol used to treat diseases of the breast and to prevent breast cancer. Obstetrics and Gynecology. 2017; 2: 106-12. (in Russian)]. https://doi.org/10.18565/aig.2017.2.106-12.
  48. Ribat Z. W., Hayder B. Sahib H.B., Khamees A.H., Al-Shammari A.M. Effect of vitex agnus castus fruits methanol extract against murine mammary adenocarcinoma cell line (amn3) and rat embryonic fibroblast normal cell line (ref). Int. J. Res. Pharm. Sci. 2019; 10(3): 1910-3. https://doi.org/10.26452/ijrps.v10i3.1393.
  49. Bischoff-Kont I., Brabenec L., Ingelfinger R., Nausch B., Furst R. BNO 1095, a Standardized Dry Extract from the Fruits of Vitex agnus-castus, Impairs Angiogenesis-related Endothelial Cell Functions In Vitro. Planta Med. 2021; 87(8): 611-9. https://doi.org/10.1055/a-1351-1038.
  50. Kim Y.W., Byzova T.V. Oxidative stress in angiogenesis and vascular disease. Blood. 2014; 123(5): 625-31. https://doi.org/10.1182/blood-2013-09-512749.
  51. Kikuchi H., Yuan B., Yuhara E., Imai M., Furutani R. et al. Involvement of histone H3 phosphorylation via the activation of p38 MAPK pathway and intracellular redox status in cytotoxicity of HL-60 cells induced by Vitex agnus-castus fruit extract. Int. J. Oncol. 2014; 45(2): 843-52. https://doi.org/10.3892/ijo.2014.2454.
  52. Ahangarpour A., Najimi S.A., Farbood Y. Effects of Vitex agnus-castus fruit on sex hormones and antioxidant indices in a d-galactose-induced aging female mouse model. J. Chin. Med. Assoc. 2016; 79(11): 589-96. https://doi.org/10.1016/j.jcma.2016.05.006.
  53. Ooi S.L., Watts S., McClean R., Pak S.C. Vitex Agnus-Castus for the Treatment of Cyclic Mastalgia: A Systematic Review and Meta-Analysis. J. Womens Health. 2020; 29(2): 262-78. https://doi.org/10.1089/jwh.2019.7770.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2022

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>